|
Market Closed -
Nasdaq
16:00:00 2026-11-19 EST
|
5-day change | 1st Jan Change | ||
| 92.07 USD | -2.61% |
|
+1.20% | +49.63% |
| 11-09 | LivaNova PLC Presents at 2026 UBS Global Healthcare Conference, Nov-09-2026 11:00 AM | |
| 11-05 | Needham Raises Price Target on LivaNova to $112 From $93, Keeps Buy Rating | MT |
Company Valuation: LivaNova PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,654 | 2,973 | 2,787 | 2,515 | 3,360 | 5,208 | - | - |
| Change | - | -36.12% | -6.24% | -9.78% | 33.61% | 55% | - | - |
| Enterprise Value (EV) 1 | 4,685 | 2,973 | 2,796 | 2,419 | 3,101 | 5,283 | 5,123 | 4,935 |
| Change | - | -36.55% | -5.94% | -13.49% | 28.21% | 70.36% | -3.03% | -3.67% |
| P/E | -32.6x | -34.5x | 162x | 39.9x | -13.8x | 28.1x | 29.1x | 24.6x |
| PBR | 3.6x | - | 2.18x | 1.91x | - | - | - | - |
| PEG | - | 0.9x | -1x | 0x | 0x | -0x | -9.05x | 1.3x |
| Capitalization / Revenue | 4.49x | 2.91x | 2.42x | 2.01x | 2.42x | 3.4x | 3.18x | 2.96x |
| EV / Revenue | 4.52x | 2.91x | 2.42x | 1.93x | 2.23x | 3.45x | 3.13x | 2.81x |
| EV / EBITDA | 26.1x | 17.7x | 14.4x | 9.15x | 9.85x | 13.9x | 12.6x | 11x |
| EV / EBIT | 30.3x | 20.5x | 16.5x | 10.1x | 10.8x | 16.3x | 14.5x | 12.6x |
| EV / FCF | - | 68.5x | 70.1x | - | 17.9x | -85.8x | 29.6x | 22.8x |
| FCF Yield | - | 1.46% | 1.43% | - | 5.59% | -1.17% | 3.38% | 4.39% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.68 | -1.61 | 0.32 | 1.16 | -4.45 | 3.361 | 3.253 | 3.85 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,035 | 1,022 | 1,154 | 1,253 | 1,388 | 1,531 | 1,639 | 1,758 |
| EBITDA 1 | 179.3 | 167.5 | 194 | 264.3 | 314.7 | 380 | 407.5 | 449.9 |
| EBIT 1 | 154.8 | 145.1 | 169.3 | 239.2 | 286.1 | 324.9 | 352.4 | 391.6 |
| Net income 1 | -135.8 | -86.2 | 17.5 | 63.2 | -242.5 | 187.5 | 164.5 | 218.1 |
| Net Debt 1 | 31.53 | - | 8.7 | -96 | -258.9 | 75 | -85 | -273 |
| Reference price 2 | 87.43 | 55.54 | 51.74 | 46.31 | 61.53 | 94.54 | 94.54 | 94.54 |
| Nbr of stocks (in thousands) | 53,225 | 53,523 | 53,871 | 54,301 | 54,606 | 55,087 | - | - |
| Announcement Date | 2/23/22 | 2/22/23 | 2/21/24 | 2/25/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 28.12x | 3.45x | 13.9x | - | 5.21B | ||
| 34.57x | 4.09x | 15.37x | 2.48% | 181B | ||
| 21.8x | 3.7x | 13.26x | 2.82% | 123B | ||
| 27.44x | 4.88x | 16.72x | 1.13% | 121B | ||
| 31.73x | 3.06x | 12.32x | 2.25% | 91.11B | ||
| 18.48x | 0.22x | 13.75x | 0.68% | 66.47B | ||
| 44.04x | 3.87x | 13.2x | 1.93% | 58.86B | ||
| 46.36x | 11.65x | 32.67x | -.--% | 55.03B | ||
| 28.13x | 6.96x | 17.65x | 1.43% | 48.88B | ||
| 48.35x | 3.5x | 12.88x | 0.49% | 35.5B | ||
| Average | 32.90x | 4.54x | 16.17x | 1.47% | 79B | |
| Weighted average by Cap. | 31.49x | 4.37x | 15.82x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LIVN Stock
- Valuation LivaNova PLC
Select your edition
All financial news and data tailored to specific country editions
















